Cargando…

Oral delivery of Hyperimmune bovine serum antibodies against CS6-expressing enterotoxigenic Escherichia coli as a prophylactic against diarrhea

BACKGROUND: . Oral administration of bovine antibodies active against enterotoxigenic Escherichia coli (ETEC) have demonstrated safety and efficacy against diarrhea in human challenge trials. The efficacy of bovine serum immunoglobulins (BSIgG) against recombinant colonization factor CS6 or whole ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Talaat, KR, Porter, CK, Bourgeois, AL, Lee, TK, Duplessis, CA, Maciel, M, Gutierrez, RL, DeNearing, B, Adjoodani, B, Adkinson, R, Testa, KJ, Feijoo, B, Alcala, AN, Brubaker, J, Beselman, A, Chakraborty, S, Sack, D, Halpern, J, Trop, S, Wu, H, Jiao, J, Sullivan, E, Riddle, MS, Joseph, SS, Poole, ST, Prouty, MG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524165/ https://www.ncbi.nlm.nih.gov/pubmed/32167011 http://dx.doi.org/10.1080/19490976.2020.1732852

Ejemplares similares

Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial
por: Talaat, Kawsar R., et al.
Publicado: (2020)

Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge
por: Harro, Clayton, et al.
Publicado: (2019)

Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers
por: Chakraborty, Subhra, et al.
Publicado: (2018)

Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli
por: Lee, Tida, et al.
Publicado: (2021)

Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine
por: Clarkson, Kristen A., et al.
Publicado: (2021)

Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
por: Talaat, Kawsar R., et al.
Publicado: (2021)

Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection
por: Chakraborty, Subhra, et al.
Publicado: (2019)

Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score
por: Porter, Chad K., et al.
Publicado: (2018)

Bioactive Immune Components of Anti-Diarrheagenic Enterotoxigenic Escherichia coli Hyperimmune Bovine Colostrum Products
por: Sears, Khandra T., et al.
Publicado: (2017)

Feasibility of avian antibodies as prophylaxis against enterotoxigenic escherichia coli colonization
por: Brumfield, Kyle, et al.
Publicado: (2022)

COVID-19 and Hyperimmune sera: A feasible plan B to fight against coronavirus
por: da Costa, Camila B.P., et al.
Publicado: (2021)

Development of a novel multiplex electrochemiluminescent-based immunoassay to aid enterotoxigenic Escherichia coli vaccine development and evaluations
por: Chakraborty, Subhra, et al.
Publicado: (2019)

Hyperimmune egg yolk antibodies developed against Clostridium perfringens antigens protect against necrotic enteritis
por: Goo, D., et al.
Publicado: (2023)

Equine hyperimmune serum protects mice against Clostridium difficile spore challenge
por: Yan, Weiwei, et al.
Publicado: (2014)

In vitro and in vivo activity of hyperimmune globulin preparations against multiresistant nosocomial pathogens
por: Rossmann, F. S., et al.
Publicado: (2014)

Production of the First Effective Hyperimmune Equine Serum Antivenom against Africanized Bees
por: Santos, Keity Souza, et al.
Publicado: (2013)

Hyperimmunized Chickens Produce Neutralizing Antibodies against SARS-CoV-2
por: Aston, Emily J., et al.
Publicado: (2022)

Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers
por: Otto, Wlodzimierz, et al.
Publicado: (2011)

An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli
por: Porter, Chad K., et al.
Publicado: (2016)

High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern
por: Moreira-Soto, Andres, et al.
Publicado: (2021)

Campylobacter jejuni transcriptional and genetic adaptation during human infection
por: Crofts, Alexander A., et al.
Publicado: (2018)

Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2
por: Burnouf, Thierry, et al.
Publicado: (2022)

Production of hyperimmune serum against genotype VII Newcastle disease virus in rabbits with several applications
por: Putri, Dwi Desmiyeni, et al.
Publicado: (2022)

Herd immunity: hyperimmune globulins for the 21st century
por: Elliott, Sarah TC, et al.
Publicado: (2018)

Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic E. coli infection and impact on intestinal colonization and ETEC specific immune responses in an experimental human challenge model
por: Brubaker, Jessica, et al.
Publicado: (2021)

ANTI-DNA ANTIBODIES IN HYPERIMMUNIZED RABBITS
por: Christian, Charles L., et al.
Publicado: (1965)

Hyperimmune Globulins for the Management of Infectious Diseases
por: Pati, Ilaria, et al.
Publicado: (2023)

Research Note: Lyophilization of hyperimmune egg yolk: effect on antibody titer and protection of broilers against Campylobacter colonization
por: Vandeputte, Jasmien, et al.
Publicado: (2020)

Preparation and development of equine hyperimmune globulin F(ab′)(2) against severe acute respiratory syndrome coronavirus
por: LU, Jai‐hai, et al.
Publicado: (2005)

Serum Antibodies Protect against Intraperitoneal Challenge with Enterotoxigenic Escherichia coli
por: Yang, Xinghong, et al.
Publicado: (2011)

Antibody activities in hyperimmune plasma against the Rhodococcus equi virulence -associated protein A or poly-N-acetyl glucosamine are associated with protection of foals against rhodococcal pneumonia
por: Kahn, Susanne K., et al.
Publicado: (2021)

Seroprevalence Study of Conserved Enterotoxigenic Escherichia coli Antigens in Globally Diverse Populations
por: Kuhlmann, Frederick Matthew, et al.
Publicado: (2023)

A multi-epitope fusion antigen candidate vaccine for Enterotoxigenic Escherichia coli is protective against strain B7A colonization in a rabbit model
por: Jones, Richard M., et al.
Publicado: (2022)

Hyperimmune Targeting Staphylococcal Toxins Effectively Protect Against USA 300 MRSA Infection in Mouse Bacteremia and Pneumonia Models
por: Han, Xiaobing, et al.
Publicado: (2022)

Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using FcγRIIIa affinity chromatography
por: Fox, Julie M., et al.
Publicado: (2023)

RHEUMATOID FACTOR PROPERTIES OF HYPERIMMUNE RABBIT SERA
por: Christian, Charles L.
Publicado: (1963)

Human Mucosal IgA Immune Responses against Enterotoxigenic Escherichia coli
por: Riaz, Saman, et al.
Publicado: (2020)

Evaluation of the Antimicrobial Activity of ZnO Nanoparticles against Enterotoxigenic Staphylococcus aureus
por: El-Masry, Reham M., et al.
Publicado: (2022)

Enterotoxigenic Escherichia coli and Vibrio cholerae Diarrhea, Bangladesh, 2004
por: Qadri, Firdausi, et al.
Publicado: (2005)

Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection
por: Giuntini, Serena, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_00051oskmhiht84u8nf37v3dum